Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neoadjuvant
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Michel Velez, MD
Date of Release
May 14th, 2025
